NCT00003686View on ClinicalTrials.gov

Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids

PHASE3TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

May 22, 1998

Primary Completion Date

November 1, 2007

Study Completion Date

December 15, 2008

Conditions
Oral ComplicationsQuality of Life
Interventions
DRUG

pilocarpine hydrochloride

Pilocarpine 5 mg po qid x 4 weeks

DRUG

Placebo

Placebo 5 mg po qid x 4 weeks

Trial Locations (2)

V5Z 4E6

BC Cancer Agency, Vancouver

M9N 1N8

Humber River Regional Hospital, Weston

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK

NCT00003686 - Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids | Biotech Hunter | Biotech Hunter